Tarbox Family Office’s Medifast MED Stock Holding History

Tarbox Family Office’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15	Closed	-$3K	–	633
2022 Q1	$3K	Hold	15	–	–	﹤0.01%	700
2021 Q4	$3K	Hold	15	–	–	﹤0.01%	795
2021 Q3	$3K	Hold	15	–	–	﹤0.01%	811
2021 Q2	$4K	Hold	15	–	–	﹤0.01%	724
2021 Q1	$3K	Hold	15	–	–	﹤0.01%	769
2020 Q4	$3K	Hold	15	–	–	﹤0.01%	702
2020 Q3	$2K	Hold	15	–	–	﹤0.01%	800
2020 Q2	$2K	Buy	15 +10	+200%	+$918	﹤0.01%	789
2020 Q1	$0	Hold	5	–	–	﹤0.01%	1234
2019 Q4	$1K	Buy	5 +2	+67%	+$194	﹤0.01%	1012
2019 Q3	$0	Hold	3	–	–	﹤0.01%	1128
2019 Q2	$0	Buy	+3	New	+$417	﹤0.01%	1113

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NPIC

Neumeier Poma Investment Counsel Carmel, California $1.46B AUM 71.13% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Tarbox Family Office's MED Position: Q2 2022 in Review

Tarbox Family Office sold out of Medifast (MED) in Q2 2022, closing a stake of 15 shares — an estimated $3K sold.

Tarbox Family Office first reported a position in MED in Q2 2019 and held it in 12 quarters. The position peaked at $4K in Q2 2021. 284 funds tracked by Wall St. Rank hold MED as of Q2 2022.

Tarbox Family Office reported no remaining Medifast position as of Q2 2022 after selling out during the quarter.
Tarbox Family Office sold 15 Medifast shares in Q2 2022, an estimated $3K.
Tarbox Family Office first reported a position in Medifast in Q2 2019 and held it in 12 quarters.
Tarbox Family Office's Medifast position peaked at $4K in Q2 2021.
284 funds tracked by Wall St. Rank held Medifast as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.